🇺🇸 FDA
Patent

US 12280159

Therapeutic protein-based nanoparticles for treating cancer

granted A61KA61K31/7105A61K47/64

Quick answer

US patent 12280159 (Therapeutic protein-based nanoparticles for treating cancer) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/7105, A61K47/64, A61K47/6929, A61K9/0085